PeptidePedia The community reference

Special:RecentChanges

Change log·6,798 revisions·page 39 of 68

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 6,798 changes are logged in total.

6,798Logged changes
575Bot edits
167Page creations
256Active editors

24 May 2025

  1. (diff | hist) 07:30 Karl Fischer titration 7,949 +649 PreregPriya (talk | contribs) expand §Interpretation on a certificate of analysis [rollback]
  2. (diff | hist) 00:40 Survodutide 4,510 ±0 TirzTaxonomist (talk | contribs) rm the equipotency claim — the cited paper does not make it [rollback]

23 May 2025

  1. (diff | hist) 17:55 TRIUMPH trial programme 4,035 +21 CagriCass (talk | contribs) label the extension study as an extension study in the table [rollback]
  2. (diff | hist) 16:00 Fasting insulin 3,910 +694 CPeptidePaddy (talk | contribs) add the pre-analytical requirement: tube type and time to separation [rollback]
  3. (diff | hist) m b 14:19 Insulin syringe unit conversion 4,444 ±0 StubSorterBot (talk | contribs) bot: repair redlinked category [rollback]
  4. (diff | hist) 11:55 Crude peptide 3,938 +22 ColdChainCleo (talk | contribs) the article confused primary and secondary drying; corrected [rollback]
  5. (diff | hist) m b 11:44 Regulatory status by jurisdiction 3,662 ±0 StubSorterBot (talk | contribs) bot: update parent category chain [rollback]
  6. (diff | hist) 09:24 Peptide harm reduction 3,975 ±0 AnalyticalAnnie (talk | contribs) split §Pricing from §Coverage [rollback]
  7. (diff | hist) 06:37 GLP-1 receptor agonist 9,758 ±0 MolarMassMaeve (talk | contribs) label the animal data as animal data in the sentence, not only in the section heading [rollback]
  8. (diff | hist) m 06:03 Chinese Peptide Company 11,789 ±0 Retention_Time_Rae (talk | contribs) add the note that this wiki publishes no score and no league table [rollback]
  9. (diff | hist) 05:01 SELECT trial 4,851 +645 SelectTrialSam (talk | contribs) name the funder in the sentence, per PP:MOS [rollback]

22 May 2025

  1. (diff | hist) 19:29 Sterile water for injection 4,413 ±0 DrTitration (talk | contribs) expand §When it is used rather than a preserved diluent [rollback]
  2. (diff | hist) 14:12 Deamidation 4,219 ±0 MassSpecMarv (talk | contribs) rm the vendor name from a methodological sentence [rollback]
  3. (diff | hist) m b 10:49 Lixisenatide 4,034 +819 StubSorterBot (talk | contribs) bot: normalise citation format [rollback]
  4. (diff | hist) 10:48 Talk:Guangzhou JEEP Biotechnology 1,170 +184 GradientGus (talk | contribs) /* Method disclosure within one report set */ reply
  5. (diff | hist) m 09:09 Shanghai Wibson Biotechnology 7,551 ±0 IncretinIvo (talk | contribs) add the standing talk-page note link to the banner [rollback]
  6. (diff | hist) m 06:14 Research use only 6,711 +22 PriorAuthPaz (talk | contribs) fix indentation in the source [rollback]
  7. (diff | hist) m 05:36 Fmoc chemistry 4,430 ±0 FreightFenna (talk | contribs) state the residual-moisture target with the method it is measured by [rollback]
  8. (diff | hist) m b 04:06 Oral semaglutide 3,542 ±0 ArchiveBot (talk | contribs) bot: sort category members [rollback]
  9. (diff | hist) m b 03:40 Underfilling 3,863 +431 StubSorterBot (talk | contribs) bot: sort category members [rollback]
  10. (diff | hist) 02:07 Body composition assessment 4,416 +32 FormularyFrida (talk | contribs) clarify that the units differ between the two cited papers [rollback]
  11. (diff | hist) 01:33 Blind sampling 7,309 +529 EndotoxinEd (talk | contribs) correct the description of the sampling procedure [rollback]
  12. (diff | hist) m 00:40 Hunan Aslsen Technology 10,052 ±0 AnalyticalAnnie (talk | contribs) expand §Reception [rollback]

21 May 2025

  1. (diff | hist) 21:08 Semaglutide 8,560 ±0 DiffWatchDov (talk | contribs) de-orphan [rollback]
  2. (diff | hist) 18:01 Liraglutide 5,268 ±0 SemaglutideSasha (talk | contribs) add the structural figure and caption it properly [rollback]
  3. (diff | hist) 17:03 Reverse-phase HPLC 5,116 ±0 HOMA_Hettie (talk | contribs) fix a dangling clause [rollback]
  4. (diff | hist) 15:54 Global access disparity 3,314 ±0 PreregPriya (talk | contribs) expand §Consequences and framing [rollback]
  5. (diff | hist) 10:56 Contract development and manufacturing organisation 4,216 ±0 CustomsClarke (talk | contribs) add the figure for the lyophilisation cycle and caption it [rollback]
  6. (diff | hist) N 09:00 Zhuhai Kerui Biotechnology 1,735 +1,735 SecondarySrc_Seb (talk | contribs) create organisation article per PP:VN
  7. (diff | hist) 08:16 Talk:Guangzhou JEEP Biotechnology 959 +119 Retention_Time_Rae (talk | contribs) /* Method disclosure within one report set */ reply
  8. (diff | hist) 08:02 Glucose-dependent insulinotropic polypeptide 6,898 +187 ProglucagonPia (talk | contribs) expand §Therapeutic exploitation [rollback]
  9. (diff | hist) 00:11 Arcuate nucleus 4,363 +42 TechnicianTeal (talk | contribs) the half-life given was for the intact peptide; label it [rollback]

20 May 2025

  1. (diff | hist) 15:33 Adverse effects of GLP-1 receptor agonists 5,314 ±0 RetinopathyRex (talk | contribs) add the note that titration exists partly to manage these effects [rollback]
  2. (diff | hist) m 15:15 Retention time 3,336 +30 RotationRosalind (talk | contribs) add the peptide-content point: area percent alone cannot give a mass [rollback]
  3. (diff | hist) 15:08 Intention-to-treat analysis 4,637 +815 FlowTrialFraser (talk | contribs) add the year of publication to each trial in the list [rollback]
  4. (diff | hist) 13:44 Talk:Guangzhou JEEP Biotechnology 748 +260 AnalyticalAnnie (talk | contribs) /* Method disclosure within one report set */ reply
  5. (diff | hist) 12:51 Placebo-adjusted effect 3,893 ±0 ParentCatPansy (talk | contribs) expand §How figures are misreported [rollback]
  6. (diff | hist) m 11:57 Reconstitution calculator 6,980 +751 CustomsClarke (talk | contribs) close an unbalanced quotation mark [rollback]
  7. (diff | hist) m b 09:51 Number needed to treat 3,631 ±0 ArchiveBot (talk | contribs) bot: expand PMID to full citation [rollback]
  8. (diff | hist) 09:29 Talk:Guangzhou JEEP Biotechnology 537 +297 GradientGus (talk | contribs) /* Method disclosure within one report set */ new section
  9. (diff | hist) m 03:22 Methionine oxidation 3,850 ±0 AnaesthesiaAoife (talk | contribs) add the repeatability figure with the number of injections [rollback]
  10. (diff | hist) 01:30 Counterfeit peptide 4,235 ±0 ChainCustodyChad (talk | contribs) expand §Substitution [rollback]
  11. (diff | hist) 01:07 Multi-dose vial 15,615 +646 FormularyFrida (talk | contribs) consistent en dashes in ranges [rollback]

19 May 2025

  1. (diff | hist) 20:05 Batch number 3,731 ±0 AnalyticalAnnie (talk | contribs) add the laboratory accreditation status, or say plainly that it is not stated [rollback]
  2. (diff | hist) m 18:02 Vial filling and stoppering 4,012 ±0 SecondarySrc_Seb (talk | contribs) attribute the stability figure to the study and its duration [rollback]
  3. (diff | hist) m 13:45 Insulin secretion 6,373 +404 TesamorelinTeg (talk | contribs) add the citation for the co-secretion finding [rollback]
  4. (diff | hist) m 13:42 Custom peptide synthesis 4,512 +735 DPP4_Dagmar (talk | contribs) add the excursion tolerance with the study it derives from [rollback]
  5. (diff | hist) 01:24 Dipeptidyl peptidase-4 6,022 ±0 DataTableDunja (talk | contribs) add the enteroendocrine cell type responsible for secretion [rollback]
  6. (diff | hist) m 00:13 Hubei Jianxiang Bioscience 5,314 +491 Chromatokid (talk | contribs) space between number and unit per PP:MOS [rollback]

18 May 2025

  1. (diff | hist) m 11:53 Proglucagon 5,743 ±0 HalfLifeHavel (talk | contribs) the half-life given was for the intact peptide; label it [rollback]
  2. (diff | hist) 10:21 Talk:Beyond-use date 1,307 +87 Ref_Desk_Ron (talk | contribs) /* Category 2 table: which revision, and should earlier revisions be shown? */ reply
  3. (diff | hist) m 08:58 Weight regain after discontinuation 4,048 +17 Areapercent_Ayo (talk | contribs) state that the frequency category follows the labelling convention [rollback]
  4. (diff | hist) m 08:19 Peptide supply chain 6,954 ±0 CounterfeitCato (talk | contribs) add the crimp-seal step to the fill-and-finish description [rollback]

17 May 2025

  1. (diff | hist) 23:32 Test report forgery 4,203 ±0 PancreasPru (talk | contribs) fix hyphenation per PP:MOS [rollback]
  2. (diff | hist) 21:31 MOTS-c 3,596 +256 MOTSc_Mira (talk | contribs) clarify that the compound is sold as an acetate salt [rollback]
  3. (diff | hist) 20:18 Peptide aggregation 4,377 ±0 TFA_Counterion (talk | contribs) split §Principle from §Practical limitations [rollback]
  4. (diff | hist) m 20:04 Preparative HPLC purification 4,598 +36 RfC_Rasmus (talk | contribs) rm a duplicated category [rollback]
  5. (diff | hist) 18:52 Temperature excursion 6,150 +318 SupplyWatchSuri (talk | contribs) alphabetise the see-also list [rollback]
  6. (diff | hist) 14:35 Qingdao Sigma Chemical 11,570 +959 ReportReaderRilla (talk | contribs) add the note that self-published material is usable only for what it states about itself [rollback]
  7. (diff | hist) 12:47 Peptide synthesis 4,134 ±0 FreightFenna (talk | contribs) add the figure for the lyophilisation cycle and caption it [rollback]
  8. (diff | hist) m b 11:49 STEP trial programme 4,391 ±0 CiteBot (talk | contribs) bot: expand PMID to full citation [rollback]
  9. (diff | hist) 07:49 Shanghai Sigma-Audley New Material Technology 9,244 +355 FmocFrancis (talk | contribs) expand §Distribution and dispatch [rollback]
  10. (diff | hist) 06:35 VendorInvestigate 4,895 +707 LedgerLysander (talk | contribs) add the turnaround time the service publishes [rollback]
  11. (diff | hist) m 01:03 Subcutaneous injection 4,640 +559 BPC_Bramwell (talk | contribs) state the assumption that the whole vial is reconstituted at once [rollback]
  12. (diff | hist) 00:42 SURMOUNT trial programme 3,589 ±0 PreregPriya (talk | contribs) name the funder in the sentence, per PP:MOS [rollback]

16 May 2025

  1. (diff | hist) 13:12 Sangon Biotech 7,533 +116 FormularyFrida (talk | contribs) expand the product-scope row in the infobox [rollback]
  2. (diff | hist) 10:05 Talk:Flourishglobal Peptide Biotech 1,170 +108 CitationChaser (talk | contribs) /* State the packing, do not explain it */ reply
  3. (diff | hist) 09:21 International nonproprietary name 3,183 ±0 MazdutideMads (talk | contribs) fix the amino-acid substitution — position 8, not position 2 [rollback]
  4. (diff | hist) 08:53 Sterility testing 3,636 ±0 PeakShapePol (talk | contribs) unpipe a link that did not need piping [rollback]
  5. (diff | hist) 08:31 Talk:Reconstitution calculator 1,170 +90 AnalyticalAnnie (talk | contribs) /* Should the default vial mass be the gross or net figure? */ reply

15 May 2025

  1. (diff | hist) m b 23:10 Peptide content 6,898 ±0 CiteBot (talk | contribs) bot: repair redlinked category [rollback]
  2. (diff | hist) m 11:32 Insulin syringe 4,667 ±0 FiveOhThreeB (talk | contribs) correct the unit conversion — U-100 not U-40 [rollback]
  3. (diff | hist) m 10:01 Dose escalation schedule 4,073 ±0 PatientPanelPru (talk | contribs) clarify which volume the graduation marks measure [rollback]
  4. (diff | hist) 09:33 Talk:Beyond-use date 1,096 +176 GMP_Gita (talk | contribs) /* Category 2 table: which revision, and should earlier revisions be shown? */ reply
  5. (diff | hist) 09:03 Talk:Reconstitution calculator 959 +209 Chromatokid (talk | contribs) /* Should the default vial mass be the gross or net figure? */ reply
  6. (diff | hist) 08:50 Talk:Flourishglobal Peptide Biotech 959 +145 FreightFenna (talk | contribs) /* State the packing, do not explain it */ reply
  7. (diff | hist) 03:47 Third-party testing 6,906 +1,136 OrforglipronOona (talk | contribs) clarify that agreement between certificate and report is a weak finding [rollback]

14 May 2025

  1. (diff | hist) 16:40 Talk:Reconstitution calculator 748 +205 MolarMassMaeve (talk | contribs) /* Should the default vial mass be the gross or net figure? */ reply
  2. (diff | hist) 16:00 Wuhan Wansheng Biotechnology 11,319 +332 RetatrutideRuben (talk | contribs) expand §Distribution and dispatch [rollback]
  3. (diff | hist) 15:44 Talk:Flourishglobal Peptide Biotech 748 +235 ColdChainCleo (talk | contribs) /* State the packing, do not explain it */ reply
  4. (diff | hist) 14:49 Talk:Beyond-use date 885 +318 Compounding_Cate (talk | contribs) /* Category 2 table: which revision, and should earlier revisions be shown? */ reply
  5. (diff | hist) 13:22 Talk:Reconstitution calculator 537 +429 AnalyticalAnnie (talk | contribs) /* Should the default vial mass be the gross or net figure? */ new section
  6. (diff | hist) 11:26 Talk:Beyond-use date 674 +271 PharmDrafts (talk | contribs) /* Category 2 table: which revision, and should earlier revisions be shown? */ new section
  7. (diff | hist) 11:20 Talk:Flourishglobal Peptide Biotech 537 +170 CitationChaser (talk | contribs) /* State the packing, do not explain it */ new section
  8. (diff | hist) 07:37 Enteroendocrine L cell 4,648 ±0 SurpassSunniva (talk | contribs) add short description [rollback]
  9. (diff | hist) 06:22 Missed dose 4,989 +582 ProglucagonPia (talk | contribs) convert the conversion list to a table so the three syringe scales align [rollback]
  10. (diff | hist) 05:10 Xi'an Mokemei Biotechnology 5,245 +159 CheckSumChase (talk | contribs) add the reception tally with its period and count stated [rollback]
  11. (diff | hist) 03:19 Purity claim inflation 4,595 ±0 TB500_Tarquin (talk | contribs) sentence case in headings per PP:MOS [rollback]
  12. (diff | hist) 02:30 Customs seizure 3,644 ±0 API_Aurora (talk | contribs) fix indentation in the source [rollback]
  13. (diff | hist) m b 01:54 Contraindications of incretin therapy 4,296 ±0 StubSorterBot (talk | contribs) bot: add maintenance category [rollback]
  14. (diff | hist) m 01:48 Lyophilisation 21,545 +645 CDMO_Caradoc (talk | contribs) add the excursion tolerance with the study it derives from [rollback]
  15. (diff | hist) m 00:22 Limit of detection 4,001 +30 ChromCleanupCass (talk | contribs) rm the vendor name from a methodological sentence [rollback]
  16. (diff | hist) 00:14 Bacterial endotoxin test 4,428 +30 DiluentDiya (talk | contribs) convert the method-comparison paragraph to a table [rollback]

13 May 2025

  1. (diff | hist) 19:46 Nantong Guangyuan Chemical 10,335 +54 ReportReaderRilla (talk | contribs) clarify that no manufacturing or marketing authorisation is claimed or established [rollback]
  2. (diff | hist) 17:50 Triple agonist 3,428 ±0 GlossaryGleb (talk | contribs) fix the amino-acid substitution — position 8, not position 2 [rollback]
  3. (diff | hist) m b 15:03 Liquid chromatography-mass spectrometry 3,724 ±0 CategoryBot (talk | contribs) bot: normalise citation format [rollback]
  4. (diff | hist) 12:03 Satiety signalling 4,470 +29 Hedgerow_Hal (talk | contribs) rm the causal claim about appetite — the cited work is associative [rollback]
  5. (diff | hist) 10:43 Retatrutide 5,894 ±0 TirzTaxonomist (talk | contribs) add the molecular formula to the infobox [rollback]
  6. (diff | hist) m 10:27 Dual incretin agonist 4,752 +18 LiraLotte (talk | contribs) expand §Design problem [rollback]
  7. (diff | hist) 04:42 Incretin effect 5,933 +165 TirzTaxonomist (talk | contribs) add the enteroendocrine cell type responsible for secretion [rollback]